Isalgen Compuesto

Quick links

Choose a section

Quick links to important sections

Advertisements

Isalgen Compuesto

Advertisements
Advertisements

Method of action: Analgesic, Antiparkinsonian

Treatment option:

Advertisements

Overview of Isalgen Compuesto

What is Isalgen Compuesto?

Isalgen Compuesto is a combination pharmaceutical product designed to manage symptoms associated with musculoskeletal conditions. It typically combines an analgesic and antipyretic agent with a skeletal muscle relaxant to provide a multifaceted approach to physical discomfort.

Composition and Mechanism

The medication is formulated with two primary active components that work through different pathways in the body:

  • Metamizole (Dipyrone): This ingredient belongs to the pyrazolone group. It functions primarily as a potent analgesic to reduce pain and an antipyretic to lower fever. It is often utilized for its ability to address acute pain when other treatments may not be suitable.
  • Methocarbamol: This component is a central nervous system (CNS) depressant with sedative and musculoskeletal relaxant properties. Rather than acting directly on the skeletal muscles, it works by inhibiting nerve impulses (or pain sensations) that are sent to the brain.

Clinical Purpose

The synergy between these two components is intended to address the cycle of pain and muscle spasms. By reducing the sensation of pain and inducing muscle relaxation, the medication aims to improve mobility and comfort in patients experiencing acute musculoskeletal distress. It is commonly associated with the treatment of conditions such as muscle strains, sprains, and back pain where muscle tension contributes significantly to the patient's discomfort.

Advertisements

What side effects are possible with Isalgen Compuesto?

Possible side effects and safety information

The official safety profile of this fixed-dose combination of Acetaminophen and Hyoscine Butylbromide is defined by the established risks associated with its two active components, as documented by regulatory agencies.


Adverse Reactions and System Groupings

Adverse reactions are classified by frequency and affected body system. Those documented as Common or Uncommon primarily include anticholinergic effects such as dry mouth, constipation, tachycardia (increased heart rate), and accommodation disorders (difficulty focusing the eyes). Other reactions affecting the skin, such as urticaria (hives) and pruritus (itching), are also listed. Rare effects include urinary retention and hypotension (decreased blood pressure).


Serious Adverse Reactions and Safety Constraints

The regulatory profile highlights the potential for serious events. These include anaphylactic shock, which is a severe allergic reaction. Due to the Acetaminophen component, there is a risk of severe hepatocellular necrosis (acute liver failure), particularly if the maximum daily dose is exceeded. This risk requires that the total intake of Acetaminophen from all sources must not exceed the specified daily limit.

Safety constraints in the labeling restrict use in certain populations. The medicine is contraindicated in patients with conditions like narrow-angle glaucoma, prostatic hypertrophy with urinary retention, severe active liver disease, and specific gastrointestinal obstructions such as mechanical stenosis or paralytic ileus. Furthermore, the medicine is not intended for continuous daily use over extended periods without medical investigation of the underlying cause of the pain.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official overdose profile for Isalgen Compuesto (Acetaminophen and Hyoscine Butylbromide) is defined by the toxicological characteristics of its components, primarily the potential for severe, delayed organ damage.

Property Official Regulatory Statement
Documented overdose presentations The profile includes Acetaminophen-induced delayed hepatotoxicity and Hyoscine-induced acute anticholinergic syndrome. Early non-specific symptoms may include Nausea, Vomiting, Pallor, and Abdominal pain.
Physiological systems affected Hepatic system (Acute Liver Failure, Hepatocellular necrosis); Cardiovascular system (Tachycardia); Renal system (Acute renal failure); CNS (Encephalopathy, Coma).
Emergency-response statements Seek immediate medical attention for the potentially severe and delayed effects. Specific management includes the administration of N-acetylcysteine (NAC) as the antidote for Acetaminophen intoxication, which is maximally protective when given early.
When immediate medical help is required Immediate medical advice must be sought, even if the patient feels well, due to the critical risk of delayed, irreversible liver damage. Urgent ophthalmological advice is required for painful, red eye with vision loss, a documented sign of potential narrow-angle glaucoma exacerbation.
Monitoring requirements Monitoring of plasma Acetaminophen concentration and hepatic function parameters, including liver transaminases (AST, ALT) and Prothrombin time (INR), is required following an overdose.

This regulatory profile mandates that urgent medical attention must be secured following any suspected overdose, irrespective of initial clinical presentation, to allow for timely supportive care and antidote administration against the dose-dependent toxicity of the active ingredients.

Advertisements

Therapeutic Uses of Isalgen Compuesto

Targeting Spasmodic Discomfort

This combination therapy is applied where symptomatic support is needed for acute spasmodic pain. It is commonly used to help manage symptoms related to visceral spasmodic pain, which includes conditions characterized by sudden, sharp cramping and pain arising from the smooth muscles of the internal organs. This is relevant in conditions such as intestinal colic, renal or biliary colic, and severe primary dysmenorrhea (menstrual cramps). The medication is applied across domains where symptomatic relief is appropriate.

“It is commonly used when symptoms cluster into patterns requiring supportive management, and may assist with maintaining comfort during periods of symptomatic strain.”

The medication is generally considered relevant for managing recurrent crampy pain and significant abdominal discomfort related to conditions like Irritable Bowel Syndrome (IBS). Its use is applied when the symptoms of pain and tension create a noticeable physiological strain, which contributes to improved comfort during periods of heightened symptoms.


Quick Fact: Relief for Acute and Recurrent Pain Property Description
Pain Type Visceral Spasmodic Pain (internal cramping)
Key Indications Colic (Renal, Biliary), Dysmenorrhea, IBS Pain
Symptom Level Moderate to Severe Cramping and Pain
Patient Benefit Supports easing the overall symptom burden

Regulatory References

  1. European Medicines Agency Pharmacovigilance Plan
Advertisements

Eligibility and Restrictions for Use

The regulatory profile for Isalgen Compuesto strictly defines who can and cannot use the medicine based on formal eligibility and non-eligibility criteria documented by health authorities. The profile establishes clear boundaries across age, organ function, and specific medical conditions.

Eligibility Status and Exclusions

Status Population/Condition
Allowed Population Adults and Adolescents/Children 10 years of age (as established in certain labels).
Not Recommended Children under 10 years of age, and individuals who are pregnant or lactating/breastfeeding.
Absolute Contraindication Severe Hepatocellular Insufficiency (Child-Pugh C), Narrow Angle Glaucoma, Myasthenia Gravis, Pathological Tachyarrhythmia, and mechanical obstructions like Megacolon or Obstructive Ileus.

Condition-Based Limitations

Use requires special caution or restriction for patients with Severe Renal Insufficiency, Mild to Moderate Hepatic Impairment (Child-Pugh A/B), Gilbert's Syndrome, and individuals prone to urinary retention or narrow angle glaucoma. These warnings are documented in the official prescribing information to guide conditional use. The eligibility profile is structured by contraindications related to the drug's anticholinergic effects and restrictions tied to the metabolism of the analgesic component.

Advertisements

What should I know about interactions with other medicines?

Isalgen Compuesto Interactions with other medicines and products

Isalgen Compuesto is a combination product whose interaction profile is determined by its active ingredients: an antispasmodic (Hyoscine butylbromide) and an analgesic (Paracetamol).

Interactions due to Hyoscine Butylbromide (Anticholinergic Activity)

Combining this medicine with other drugs that have anticholinergic properties can lead to an additive increase in side effects. Medications in this category include certain antihistamines, tricyclic antidepressants, antipsychotics, and other antispasmodics. These combinations may heighten the risk of confusion, severe drowsiness, dry mouth, blurred vision, and difficulty with urination or constipation. Concomitant use with agents that affect the central nervous system, such as sedatives and opioids, may also increase the risk of excessive sedation and dizziness.

Interactions due to Paracetamol (Acetaminophen)

The Paracetamol component requires caution when used with other products containing acetaminophen to avoid exceeding the maximum recommended daily dose, which can lead to severe liver injury. Paracetamol may interact with certain blood-thinning medicines (oral anticoagulants); regular monitoring is recommended if these are taken together.

Product and Lifestyle Interactions

Consumption of alcohol must be avoided or strictly limited due to a significantly increased risk of liver damage caused by Paracetamol and enhanced central nervous system side effects from the Hyoscine component, such as severe drowsiness and impaired coordination.

Advertisements

Mechanism of Action

The mechanism of action involves the coordinated activity of two ingredients, each targeting a distinct physiological system: one to modulate nociceptive signaling, and the other to modulate involuntary muscular tone.

Modulating Central Nociceptive Signals

This domain involves the action of Acetaminophen, which acts as a weak inhibitor of the Cyclooxygenase (COX) enzyme system, primarily within the Central Nervous System (CNS). This inhibition reduces the synthesis of pain-sensitizing prostaglandins ( PGE2), which in turn lowers the excitability of central pain pathways. The resulting physiological effect is the elevation of the pain threshold, modulating the magnitude of nociceptive signal processing.

Blocking Visceral Smooth Muscle Contraction

This domain involves the action of Hyoscine Butylbromide, a non-selective competitive antagonist that blocks muscarinic cholinergic receptors located on the smooth muscle of internal organs. By preventing the binding of the neurotransmitter acetylcholine, the drug interrupts the parasympathetic signaling cascade that drives involuntary muscle contraction. The resulting physiological effect is smooth muscle relaxation (spasmolysis), which modulates excessive muscular contractile force.

Complementary Dual-Pathway Intervention

The two mechanisms exhibit a complementary synergy: one action targets the peripheral mechanical pathway associated with muscle contraction by limiting muscle activity, while the other targets the resulting central nociceptive signal processing by raising the pain threshold. This simultaneous intervention across two different systems contributes to the compound's overall physiological effect.

Advertisements

Dosage and Administration Information

How Isalgen Compuesto is Used

Isalgen Compuesto, a fixed-dose combination of Hyoscine Butylbromide (10 mg) and Acetaminophen (500 mg), is intended for oral administration as a film-coated tablet. Its usage is defined by specific guidelines focusing on dosage and administration parameters.


Official Administration Guidelines

The standard adult regimen involves taking one to two tablets per single dose, with administration occurring up to three times daily. The dosing must not result in a total consumption exceeding six tablets (or 3000 mg of Acetaminophen) within a 24-hour period. This short-term use constraint is primarily in place due to the Acetaminophen component.

Administration Parameter Official Requirement
Route of Administration Oral route only.
Preparation Requirements Tablets must be swallowed whole with sufficient liquid; do not crush or chew.
Course Duration Limit Should not be taken for more than three consecutive days without medical advice.
Age Restriction Not suitable for use in children under 10 years of age.

Contextual Use Constraints

The medicine may generally be taken with or without food as no specific timing constraint relating to meals is mandated. A critical constraint for proper use is the mandate to avoid concurrent use of other products containing Paracetamol (Acetaminophen) to ensure the total daily dosage limit is not unintentionally surpassed, maintaining strict dose control. In patients with impaired hepatic or renal function, the interval between doses may need to be prolonged as determined by a healthcare professional.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Isalgen Compuesto

This overview presents the structure of the clinical research for this medicine, focusing only on the types of studies conducted, the populations included, and the specific outcomes examined in official scientific literature.


Evidence Base for Recurrent Crampy Abdominal Pain

Research has explored the fixed-dose combination (FDC) of Acetaminophen and Hyoscine Butylbromide in recurrent crampy abdominal pain and primary dysmenorrhea. Studies include Randomized Controlled Trials (RCTs) against placebo and individual components, which monitored outcomes related to physical discomfort and patient-reported outcomes using standardized scales. These trials studied adults and adolescents, examining short-term symptom evolution and the impact on daily functioning. Findings describe group patterns related to symptom change, but research does not determine whether an individual will respond similarly.


Research for Acute Spasmodic Pain and Special Populations

The combination was studied for acute, non-specific colicky abdominal pain in settings like emergency departments. These acute care studies explored short-term symptom changes, measuring pain intensity at defined intervals (e.g., 80 minutes) and the subsequent administration of rescue analgesia. Data for this combination, or its components, were included in studies of children and adolescents.

However, data for certain groups, such as the older adult population or those with complex comorbid conditions, are not well characterized. Research provides context but not individual predictions for groups outside of those specifically studied.


Duration and Limitations in the Research

The available evidence explores short-term symptom changes, differentiating between single-dose acute effects and observations over short-term treatment courses (e.g., up to three weeks). Long-term outcomes remain uncertain; there is limited information, and sustained symptom evolution beyond short-term usage is still emerging. Additionally, some evidence relies on comparative trials of the individual components, meaning comparative evidence may be limited for the specific FDC in all contexts. Research is ongoing, and data for chronic conditions remain insufficient.

Key Studies & References European Medicines Agency: Pharmacovigilance Plan Buscapina Compositum N - Submitted document

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Isalgen Compuesto (FAQ)

Q: Is Isalgen Compuesto used for the same conditions as other common medicines in its class?

This medicine is officially indicated for the relief of spasmodic pain, particularly in the gastrointestinal or urinary tracts. The specific therapeutic niche of Isalgen Compuesto is defined by its dual-action approach, combining a pain reliever (analgesic) with a muscle relaxer (antispasmodic). This strategic combination targets both the muscle spasm itself and the central perception of the resulting discomfort.


Q: What does 'Compuesto' mean in the drug name, and why is it important?

The word 'Compuesto' is Spanish for 'compound' or 'combined,' and it refers to the composition of the medicine. Isalgen Compuesto is a fixed-dose combination medicine, meaning it contains two distinct active ingredients in a single tablet. These are Acetaminophen (a pain reliever) and Hyoscine Butylbromide (a spasm reliever), which work together to address pain caused by muscle cramping.


Q: Why do some people say they use Isalgen Compuesto for a different reason than what is listed as its primary purpose?

The official purpose of this medicine, as defined by regulatory documents, is strictly limited to conditions like spasmodic pain. If individuals report using the medicine for reasons other than those listed in the official indications, it is considered use that is not supported by the regulatory labeling. Official information states the medicine's use is defined by the specific conditions it is indicated to treat.


Q: Why do health forums often mention the need for liver function monitoring with this medicine?

Official warnings are in place due to the Acetaminophen component, which carries a risk of liver injury, especially if the maximum daily dose is exceeded or if the medicine is used for long periods. Regulatory documentation indicates that monitoring of liver function (along with renal function and blood count) is a required consideration if the medicine is used for a prolonged time. This monitoring is typically managed by a healthcare professional.


Q: What is the expected outcome if the drug is taken exactly as described in the official instructions?

Official clinical studies support that the combined approach of relaxing spasms and raising the pain threshold has been shown to aid in the relief of crampy abdominal pain in group settings. However, official information uses uncertainty-respecting language, noting that individual response can vary. The medicine is intended to provide short-term symptomatic relief for acute discomfort.


Q: I noticed the packaging says 'may cause drowsiness'; what does that typically mean for daily activities?

The Hyoscine component has the potential to cause side effects such as drowsiness or fatigue. Due to this possibility, official warnings advise that patients should exercise caution. If a person experiences these effects, official warnings indicate that driving or operating heavy machinery is advised against if affected.


Q: What are the circumstances under which regulatory agencies recommend stopping the medicine?

Regulatory documents describe that immediate cessation of treatment is required if severe symptoms are observed, such as persistent or worsening severe abdominal pain, high fever, or signs of a serious reaction like severe rash. Official warnings indicate that medical attention must be sought immediately if any of these critical conditions occur.


Q: What is the reason this drug is typically only available by prescription?

The legal classification of this medicine (whether it requires a prescription or is available over-the-counter) varies depending on the regulatory region. When restricted to prescription-only use, this is generally due to the need for professional supervision. The restriction addresses the potential risks associated with Paracetamol overdose and the anticholinergic side effects of the Hyoscine component.


Q: How does the evidence compare for the different ingredients in Isalgen Compuesto?

Official clinical research includes studies that compare the effects of the fixed combination against its individual components. These comparative studies generally describe findings that support greater relief for spasmodic pain compared to using the analgesic component (Acetaminophen) alone. This supports the benefit of the dual-action formulation.


Q: How quickly do people typically expect to see any kind of change after starting this medicine?

While the full effect of the two ingredients varies, patient information leaflets often report that the antispasmodic component begins working relatively quickly. This effect—the muscle relaxing action—is generally reported to start soothing the pain or spasms within approximately 15 minutes of administration.


Q: If I miss a dose, what is the description of the drug's effect duration?

Official labeling defines the protocol for a missed dose. The instructions state that if a dose is forgotten, it is to be taken as soon as it is remembered, provided it is not near the time for the next scheduled dose. The protocol requires that if the next dose is due shortly, the missed dose is skipped, and no more than one dose is to be taken at that time.


Q: Is a headache a listed common side effect of Isalgen Compuesto?

Official safety documents classify side effects by how often they occur in clinical trials (e.g., Frequent or Uncommon). Headache is not listed among the commonly reported side effects in the official safety profile for this medicine.


Q: I'm confused about the difference between a side effect and an adverse reaction; what is the official distinction?

In regulatory terminology, a side effect often refers to a secondary, usually predictable, and often undesirable effect that occurs at normal therapeutic doses. An adverse reaction is a broader term for any harmful or unintended response to a medicine that may be more serious and potentially requires medical intervention.


Q: Is the name 'Isalgen Compuesto' internationally recognized, or does it change by country?

Official regulatory bodies recognize the combination of Hyoscine Butylbromide and Paracetamol internationally, but the commercial name varies significantly across different countries. This combination may be marketed under various names (e.g., Buscopan Plus, Spasmodex-P, Isalgen Compuesto), depending on the specific regulatory jurisdiction.


Q: What happens if I stop taking Isalgen Compuesto suddenly?

Regulatory documents state that this medicine is intended for short-term use. Warnings are included that advise that abrupt discontinuation of analgesics after prolonged high-dose use may induce withdrawal symptoms, such as headache or general tiredness. Since the medicine is defined for acute relief and short-term use, the general risk of these withdrawal symptoms is considered low when used as intended.


Q: Does Isalgen Compuesto interfere with common lab test results?

Official product information states that the Paracetamol component may interfere with the accuracy of certain laboratory test results. Specifically, this interference can affect tests used to determine levels of uric acid (using phosphotungstic acid) and blood glucose (using glucose oxidase-peroxidase) in the body.


Q: What are the general expectations about follow-up appointments when taking this medicine?

Official warnings and precautions primarily focus on the conditions under which a person is required to seek immediate medical advice, such as if pain worsens or they experience severe symptoms. Information does not specify a routine follow-up schedule or frequency. The schedule for monitoring and follow-up is a clinical decision determined by the individual's healthcare provider based on their specific condition.


Q: What is the information on whether Isalgen Compuesto is addictive or habit-forming?

Based on the official classification of its components, this product is generally considered to have a low potential for abuse. The medicine is not centrally active in a way that typically leads to dependence. Therefore, it is classified as not being habit-forming or addictive.


Q: Why is the drug described as having a specific route of elimination from the body?

Official pharmacokinetic data describes how the body processes and removes the medicine. The two active ingredients are primarily eliminated from the body through two routes: the kidneys and metabolism (breakdown) by the liver. Acetaminophen is converted into inactive compounds in the liver before being removed by the kidneys.

Advertisements

How should Isalgen Compuesto be stored and disposed of?

The official regulatory requirements for the storage and disposal of Isalgen Compuesto tablets are designed to protect the medicine's integrity.

Official Storage Conditions

Requirement Regulatory Statement
Temperature Store at a temperature not exceeding 30 C.
Protection Must be protected from light and stored in a dry place (protected from moisture).
Packaging Must be kept in its original package.

The medicine should be stored at controlled room temperature and kept out of the sight and reach of children. Exceeding the maximum temperature limit or exposure to excessive moisture may compromise the product's stability.

Disposal Instructions

Disposal of unused or expired tablets must be according to local regulations for pharmaceutical waste. The product must not be flushed down the sink or toilet, as it is not on the official 'flush list.' Unused medicine should be rendered undesirable before disposal in the household trash, if a take-back program is unavailable.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Isalgen Compuesto found in:

A-Z Index: